Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yusuke Okujima"'
Autor:
Yusuke Okujima, Takao Watanabe, Takeshi Ito, Yasumichi Inoue, Yutaka Kasai, Yusuke Imai, Yoshiko Nakamura, Mitsuhito Koizumi, Osamu Yoshida, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Ryosuke Kawakami, Takashi Saitou, Takeshi Imamura, Yoshinori Murakami, Yoichi Hiasa
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract RNA-dependent protein kinase (PKR) may have a positive regulatory role in controlling tumor growth and progression in hepatocellular carcinoma (HCC). However, the downstream substrates and the molecular mechanism of PKR in the growth and pro
Externí odkaz:
https://doaj.org/article/dd42980cfe6a449483d6c8e426e3ad7c
Autor:
Mitsuhito Koizumi, Sho Ishikawa, Kaori Marui, Masahito Kokubu, Yusuke Okujima, Yuki Numata, Yoshiki Imamura, Teru Kumagi, Yoichi Hiasa
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 21, p2943-2947, 5p
Autor:
Kaori, Hino, Tomohiro, Nishina, Yuuki, Numata, Akinori, Asagi, Tomonori, Inoue, Megumi, Yoshimatsu, Chihiro, Sakaguchi, Akio, Nakasya, Norifumi, Nishide, Takeshi, Kajiwara, Takashi, Terao, Seijin, Nadano, Kaori, Marui, Yusuke, Okujima, Masahito, Kokubu, Yoshiki, Imamura, Kozue, Kanemitsu, Mitsuhito, Koizumi, Teru, Kumagi, Yoichi, Hiasa, Ichinosuke, Hyodo
Publikováno v:
Internal Medicine. 61:2255-2261
Objective S-1 and modified FOLFIRINOX (mFFX) were often used as the second-line chemotherapies after failure of gemcitabine plus nab-paclitaxel (GnP) in unresectable pancreatic cancer (UPC) until nanoliposomal irinotecan plus 5-fluorouracil/leucovori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37c1a7b3582a7a6ff72a10464034314
https://doi.org/10.2169/internalmedicine.8736-21
https://doi.org/10.2169/internalmedicine.8736-21
Autor:
Kouji Joko, Yasunori Moriyama, Ryo Yano, Hironori Ochi, Nobuaki Azemoto, Kaori Sato, Michiko Aono, Masataka Nishiyama, Shunji Takechi, Ryosuke Jinoka, Toshie Mashiba, Tomoyuki Yokota, Yusuke Okujima
Publikováno v:
Euroasian Journal of Hepato-Gastroenterology
Background A possible interaction of hepatitis viruses at cellular and molecular levels has been suggested. Eradication of hepatitis C virus (HCV) has been reported to induce activation of hepatitis B virus (HBV)-related liver diseases. Materials and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43b7087486463c524236c7d2f414ca8
http://europepmc.org/articles/PMC7047307
http://europepmc.org/articles/PMC7047307
Autor:
Hironori Ochi, Kouji Joko, Nobuaki Azemoto, Tomoyuki Yokota, Masayuki Kurosaki, Michiko Aono, Kaori Sato, Ryo Yano, Yusuke Okujima, Namiki Izumi, Toshie Mashiba
Publikováno v:
Journal of Hepatology. 70:e232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::223626a85db7a402a132e69837476454
https://doi.org/10.1016/s0618-8278(19)30434-7
https://doi.org/10.1016/s0618-8278(19)30434-7